JBT Corporation 2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023; filed February 23, 2024. The filing is for John Bean Technologies Corporation (NYSE: JBT), not an entity identified as JBT MAREL Corp. Unless otherwise noted, amounts below are in U.S. dollars.
Business context and reporting period
JBT supplies food and beverage processing equipment, integrated systems, aftermarket parts and services, software, and automated guided vehicle systems. Continuing operations are reported as one segment. Recurring revenue was 51% of 2023 revenue.
JBT completed the sale of its AeroTech business to Oshkosh on August 1, 2023, as part of its strategy to focus on food and beverage solutions. AeroTech is presented as discontinued operations.
Financial results and liquidity
| Metric | 2023 | 2022 |
|---|---|---|
| Revenue from continuing operations | $1,664.4 million | $1,590.3 million |
| Gross profit / margin | $585.7 million / 35.2% | $529.4 million / 33.3% |
| Operating income | $164.7 million | $132.6 million |
| Income from continuing operations | $129.3 million | $103.8 million |
| Adjusted EBITDA from continuing operations | $273.1 million; 16.4% margin | $227.7 million; 14.3% margin |
| Net income, including discontinued operations | $582.6 million | $137.4 million |
| Cash from continuing operating activities | $74.2 million | $135.2 million |
| Cash and cash equivalents at year-end | $483.3 million | $71.7 million |
| Long-term debt, net | $646.4 million | $977.3 million |
Fourth-quarter 2023 revenue was $444.6 million versus $441.2 million in Q4 2022. Continuing-operations income was $52.7 million versus $31.2 million. Net income was $81.1 million versus $41.0 million; Q3 2023 net income was unusually high due largely to the AeroTech sale.
JBT reported $1.2 billion of liquidity, including cash and available revolving-credit capacity. At year-end, $250.0 million was drawn on the revolving facility, with $1,043.8 million available, subject to covenant compliance. The company reported covenant compliance. The $402.5 million convertible notes mature in 2026 and carry a 0.25% coupon.
Material changes versus the prior comparable period
- Continuing-operations revenue rose 4.7%. Acquisitions contributed $76.8 million; organic revenue grew $4.7 million, while foreign-currency translation reduced revenue by $7.4 million.
- Gross margin rose 190 basis points, primarily reflecting pricing, restructuring savings, and a greater mix of recurring revenue; lower equipment volume partly offset improvement.
- Continuing-operations income increased 24.6%, and Adjusted EBITDA increased 19.9%.
- Operating cash flow from continuing operations declined $61.0 million, primarily because of $133.2 million of taxes paid on the AeroTech sale. Excluding that payment, management said continuing operating cash flow increased year over year.
- AeroTech sale proceeds were $808.2 million. JBT used proceeds to repay $305.4 million of debt and paid transaction costs, sale-related taxes, and a pension contribution. The sale generated a reported $443.7 million after-tax gain; discontinued operations also include AeroTech’s operating results.
- During Q4, JBT changed certain inventory valuation from LIFO to FIFO, retrospectively adjusting prior periods. The change increased 2023 continuing-operations income by $1.6 million versus LIFO, while reducing reported 2023 net income by $23.1 million, primarily because of the discontinued-operations impact.
Outlook, commentary, risks and unusual items
- Management expected demand to improve in 2024, citing anticipated lower interest rates, improving poultry-market dynamics, and organic growth initiatives. It expected further margin improvement from continuous improvement, restructuring, and sourcing actions. This is qualitative outlook, not a numerical earnings forecast.
- Management expected 2024 capital expenditures of $50 million to $60 million and said it expected to recognize the remaining restructuring charges, bringing the plan’s total estimated net cost to $17 million–$18 million, by Q1 2024. Cumulative annualized savings reported at year-end were $11.1 million; further savings were expected in 2024.
- Year-end backlog was $678.2 million, up $13.8 million year over year; JBT expected to recognize 93% as revenue in 2024. Inbound orders rose to $1,667.5 million from $1,587.4 million.
- JBT disclosed an intended voluntary tender offer for all Marel shares, expected to launch in Q2 2024, subject to confirmatory diligence, negotiations, and Board approval. Completion would require, among other conditions, at least 90% acceptance by Marel shareholders and required regulatory and JBT shareholder approvals. The filing warns of execution, integration, dilution, financing, and increased-debt risks; the transaction was not completed as of the filing.
- Key operating risks include economic and interest-rate conditions, customer investment patterns, poultry-market conditions, supply-chain and input-cost pressures, labor availability, fixed-price project cost overruns, foreign-exchange exposure, cyber incidents, and execution of restructuring and digital initiatives.
- Cash from operations was also affected by U.S. tax rules requiring research and development costs to be amortized rather than deducted immediately; JBT estimated a further approximately $10 million reduction in 2024 operating cash flow from this requirement.
- Management said ordinary-course legal matters were not expected to have a material adverse effect overall, while noting an unfavorable resolution could materially affect a particular future period. The auditor identified cost-to-completion estimates for over-time product revenue as a critical audit matter; $615.2 million of 2023 product revenue used the cost-to-cost method.
Most important facts for investors to verify
- Progress, terms, required approvals, financing, dilution, and integration implications of the proposed Marel transaction.
- Whether 2024 demand and margin expectations materialize, and whether the forecast backlog converts as expected.
- Recurring-revenue growth and the sustainability of margin improvement after restructuring and sourcing benefits.
- Cash generation after the AeroTech-related tax payment, planned capital expenditures, and remaining restructuring spending.
- Debt, revolving-credit availability, covenant headroom, and any financing needed for a Marel offer.
- Project cost estimates underlying over-time revenue recognition and the effects of the retrospective FIFO accounting change when comparing periods.